Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus

Developing a medication to cure and manage diabetes mellitus complications is of interest in medicinal chemistry. Toward this end, six bis-biphenyl-salicylaldehyde Schiff base derivatives have been evaluated for their α-glucosidase inhibition, antiglycation and anti-inflammation potentials. Four com...

Full description

Saved in:
Bibliographic Details
Main Authors: Daoud Safa, Thiab Samar, Jazzazi Taghreed M. A., Al-Shboul Tareq M. A., Ullah Saeed
Format: Article
Language:English
Published: Sciendo 2022-09-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2022-0019
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832573322582294528
author Daoud Safa
Thiab Samar
Jazzazi Taghreed M. A.
Al-Shboul Tareq M. A.
Ullah Saeed
author_facet Daoud Safa
Thiab Samar
Jazzazi Taghreed M. A.
Al-Shboul Tareq M. A.
Ullah Saeed
author_sort Daoud Safa
collection DOAJ
description Developing a medication to cure and manage diabetes mellitus complications is of interest in medicinal chemistry. Toward this end, six bis-biphenyl-salicylaldehyde Schiff base derivatives have been evaluated for their α-glucosidase inhibition, antiglycation and anti-inflammation potentials. Four compounds (compounds 2–5) showed an excellent α-glucosidase inhibitory effect superior to that produced by acarbose. Additionally, the docking study revealed that these compounds are anchored within the binding pocket of α-glucosidase via hydrogen bonding, π-stacking and hydrophobic interactions, comparable to a high number of hydrogen bonding involved in anchoring acarbose. Interestingly, all tested compounds showed varying degrees of antiglycation activity with superior activity for two of them (compound 1 and compound 6) compared to the standard rutin. Moreover, the results indicated an outstanding anti-inflammatory activity for two compounds (compounds 1 and 6) compared to ibuprofen.
format Article
id doaj-art-eac0f7e8c6a94c6d86eb43b88fbaa3f6
institution Kabale University
issn 1846-9558
language English
publishDate 2022-09-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-eac0f7e8c6a94c6d86eb43b88fbaa3f62025-02-02T05:15:57ZengSciendoActa Pharmaceutica1846-95582022-09-0172344945810.2478/acph-2022-0019Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitusDaoud Safa0Thiab Samar1Jazzazi Taghreed M. A.2Al-Shboul Tareq M. A.3Ullah Saeed4Department of Pharmaceutical Chemistry and Pharmacognosy Faculty of Pharmacy, Applied Science Private University, Amman, JordanDepartment of Pharmaceutical Chemistry and Pharmacognosy Faculty of Pharmacy, Applied Science Private University, Amman, JordanDepartment of Chemistry, Yarmouk University, Irbid, JordanDepartment of Chemistry and Chemical Technology, Tafila Technical University Tafila, JordanH. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences University of Karachi, Karachi-75270PakistanDeveloping a medication to cure and manage diabetes mellitus complications is of interest in medicinal chemistry. Toward this end, six bis-biphenyl-salicylaldehyde Schiff base derivatives have been evaluated for their α-glucosidase inhibition, antiglycation and anti-inflammation potentials. Four compounds (compounds 2–5) showed an excellent α-glucosidase inhibitory effect superior to that produced by acarbose. Additionally, the docking study revealed that these compounds are anchored within the binding pocket of α-glucosidase via hydrogen bonding, π-stacking and hydrophobic interactions, comparable to a high number of hydrogen bonding involved in anchoring acarbose. Interestingly, all tested compounds showed varying degrees of antiglycation activity with superior activity for two of them (compound 1 and compound 6) compared to the standard rutin. Moreover, the results indicated an outstanding anti-inflammatory activity for two compounds (compounds 1 and 6) compared to ibuprofen.https://doi.org/10.2478/acph-2022-0019bis-schiff basesdiabetes mellitusglycationpostprandial hyperglycemiaα-glucosidasedocking study
spellingShingle Daoud Safa
Thiab Samar
Jazzazi Taghreed M. A.
Al-Shboul Tareq M. A.
Ullah Saeed
Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus
Acta Pharmaceutica
bis-schiff bases
diabetes mellitus
glycation
postprandial hyperglycemia
α-glucosidase
docking study
title Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus
title_full Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus
title_fullStr Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus
title_full_unstemmed Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus
title_short Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus
title_sort evaluation and molecular modelling of bis schiff base derivatives as potential leads for management of diabetes mellitus
topic bis-schiff bases
diabetes mellitus
glycation
postprandial hyperglycemia
α-glucosidase
docking study
url https://doi.org/10.2478/acph-2022-0019
work_keys_str_mv AT daoudsafa evaluationandmolecularmodellingofbisschiffbasederivativesaspotentialleadsformanagementofdiabetesmellitus
AT thiabsamar evaluationandmolecularmodellingofbisschiffbasederivativesaspotentialleadsformanagementofdiabetesmellitus
AT jazzazitaghreedma evaluationandmolecularmodellingofbisschiffbasederivativesaspotentialleadsformanagementofdiabetesmellitus
AT alshboultareqma evaluationandmolecularmodellingofbisschiffbasederivativesaspotentialleadsformanagementofdiabetesmellitus
AT ullahsaeed evaluationandmolecularmodellingofbisschiffbasederivativesaspotentialleadsformanagementofdiabetesmellitus